|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,565.40 INR | +2.75% |
|
+2.85% | +1.09% |
| 06-02 | Alkem Laboratories Limited Launches Semaglutide in Single-Shot Pre-Filled Syringes At Price Starting Inr 350 | CI |
| 06-02 | Alkem Laboratories Shows Strong Moves But Weak Follow-Through |  |
| Market Cap | 648B 6.85B 6B 5.54B 5.17B 9.73B 9.96B 66.63B 25.72B 319B 25.72B 25.16B 1,109B | P/E 2026 |
27.5x | P/E 2027 * | 27.6x |
|---|---|---|---|---|---|
| Enterprise Value | 619B 6.55B 5.74B 5.3B 4.95B 9.31B 9.52B 63.74B 24.61B 306B 24.61B 24.07B 1,061B | EV / Sales 2026 |
4.3x | EV / Sales 2027 * | 3.73x |
| Free-Float |
37.09% | Yield 2026 |
1% | Yield 2027 * | 0.95% |
Last Transcript: Alkem Laboratories Limited
| 1 day | +2.75% | ||
| 1 week | +2.85% | ||
| Current month | +1.23% | ||
| 1 month | +4.67% | ||
| 3 months | +4.94% | ||
| 6 months | +2.66% | ||
| Current year | +1.09% |
| 1 week | 5,395.5 |  | 5,576 |
| 1 month | 5,164 | | 5,576 |
| Current year | 5,085 | | 5,933 |
| 1 year | 4,716.75 | | 5,933 |
| 3 years | 3,440.05 | | 6,440 |
| 5 years | 2,835 | | 6,440 |
| 10 years | 1,342 | | 6,440 |
| Manager | Title | Age | Since |
|---|---|---|---|
Vikas Gupta
CEO | Chief Executive Officer | - | 22/09/2023 |
Rajorshi Ganguli
PSD | President | - | - |
Akhilesh Sharma
PSD | President | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sandeep Singh
BRD | Director/Board Member | 43 | 09/08/2013 |
| Director/Board Member | 63 | 11/02/2008 | |
Sarvesh Singh
BRD | Director/Board Member | 44 | 11/11/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.75% | +2.85% | - | - | 6.85B | |
| +1.81% | +11.60% | +58.61% | +164.79% | 1,097B | |
| +1.51% | +11.77% | +69.61% | +57.53% | 622B | |
| +0.38% | +10.56% | +39.49% | +90.88% | 449B | |
| -0.84% | +6.34% | +29.51% | +24.01% | 334B | |
| +0.68% | +6.14% | +42.53% | +27.92% | 294B | |
| +1.01% | +3.22% | +32.47% | +41.56% | 286B | |
| +1.51% | +3.85% | -27.30% | -41.86% | 213B | |
| +0.62% | +4.59% | +30.10% | +63.03% | 195B | |
| -1.21% | +1.17% | +14.15% | +66.20% | 157B | |
| Average | +0.67% | +6.79% | +32.13% | +54.90% | 405.19B | |
| Weighted average by Cap. | +0.79% | +8.72% | +43.67% | +82.05% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 146B 1.55B 1.35B 1.25B 1.17B 2.2B 2.25B 15.05B 5.81B 72.14B 5.81B 5.68B 250B | 166B 1.75B 1.53B 1.42B 1.32B 2.49B 2.54B 17.03B 6.58B 81.67B 6.58B 6.43B 284B |
| Net income | 25.13B 266M 233M 215M 201M 378M 386M 2.59B 998M 12.4B 998M 976M 43.04B | 23.92B 253M 222M 205M 191M 360M 368M 2.46B 950M 11.8B 950M 929M 40.98B |
| Net Debt | -28.13B -298M -261M -241M -225M -423M -432M -2.89B -1.12B -13.88B -1.12B -1.09B -48.19B | -30.47B -322M -282M -261M -243M -458M -468M -3.14B -1.21B -15.03B -1.21B -1.18B -52.2B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/06/26 | ₹5,565.40 | +2.75% | 137,183 |
| 29/06/26 | ₹5,416.70 | -0.09% | 14,497 |
| 25/06/26 | ₹5,421.65 | -0.17% | 93,973 |
| 24/06/26 | ₹5,431.05 | +0.37% | 1,300 |
| 23/06/26 | ₹5,411.25 | +0.84% | 77,494 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALKEM Stock
- ALKEM Stock
Select your edition
All financial news and data tailored to specific country editions
